v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 31,206,707 $ 139,220,208
Marketable securities 127,812,140 39,543,820
Prepaid research and development 2,346,641 1,001,993
Prepaid expenses and other current assets 933,938 343,374
Deferred offering costs 44,489 0
Total current assets 162,343,915 180,109,395
Prepaid research and development, noncurrent 1,000,000 1,000,000
Other assets 244,697 95,121
Total assets 163,588,612 181,204,516
Current liabilities:    
Accounts payable 991,720 1,158,054
Accrued expenses and other current liabilities 9,268,306 4,081,282
Contingent consideration liability 0 3,061,501
Total current liabilities 10,260,026 8,300,837
Total liabilities 10,260,026 8,300,837
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value; 500,000,000 shares authorized; 132,032,636 and 131,691,237 shares issued and outstanding (including 0 and 4,149,252 contingently issuable shares - see Note 10) at June 30, 2026 and December 31, 2025, respectively 132,032 131,691
Additional paid-in capital 331,921,179 315,429,986
Accumulated other comprehensive income (loss) (72,754) 21,802
Accumulated deficit (178,651,871) (142,679,800)
Total stockholders' equity 153,328,586 172,903,679
Total liabilities and stockholders' equity $ 163,588,612 $ 181,204,516